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Background
We have in an epidemiological study identified a group of
individuals with multiple asthma symptoms (MSA) that
reflect a more severe and uncontrolled disease. An altered
innate immunity and adaptive immunity, and effects of
microorganisms may play a role in the development of
both CRS and asthma. The innate immune system use
Toll-like receptors (TLRs) to recognize microbes and acti-
vate defense mechanisms within minutes of microbial
invasion which is followed by an antigen-specific response
by the adaptive immune system. Thus, innate and adaptive
immune cells are sequentially activated and reciprocally
regulate one another. Glycogen synthase kinase-3b
(GSK3b) has been demonstrated as a regulator of both
innate and adaptive immunity. GSK3b was shown to mod-
ulate inflammatory responses through TLR-mediated pro-
duction of pro-inflammatory cytokines and inactivation of
GSK3b (phosphorylated GSK3b) lead to a reduced IL-12
production, which was suggested to skew the balance
towards a Th2 response.
Aim
To determine the degree of expression of TLRs 2, 4, 7 and
9 on monocytes as well phGSK3b using flow cytometry.
We hypothesize that the co-existence of CRS in patients
with asthma and especially patients with MSA has an
increased TLR expression involved in the innate immune
system.
Method
Participants were selected from an epidemiological cohort,
the West Sweden Asthma Study. Clinical parameters as
well as fresh peripheral blood cells were obtained from
one group of non-asthmatic subjects with CRS (CRS) and
four different groups of asthmatics: 7 subjects with MSA
(MSA), 7 subjects with other asthma (OA), 7 subjects with
MSA and CRS (MSA/CRS) and 9 subjects with OA and
CRS (OA/CRS). These five groups were compared to a
control group consisting of 10 healthy subjects without
asthma or CRS.
Results
Individuals with MSA or CRS only, showed significantly
increased TLR2, TLR7 and TLR9 expression (rMFI) on
CD14+ monocytes compared to controls as well as the
expression of phGSK3b and CD14. Individuals in the com-
bined MSA/CRS group showed increased expression of
CD14 and TLR2, but increased expression of TLR4 was
only found in the CRS group.
Conclusion
The upregulated expression of TLRs in the MSA group
compared to control group suggest a higher susceptibility
towards an altered immune response that might reflect the
degree of severity. Furthermore, the increased phosphoryla-
tion of GSK3b may indicate a switch in the immune
response from a pro-inflammatory to a dysregulated Th2
response.
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